D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 46.88 CNY -1.62% Market Closed
Market Cap: 19.5B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Gross Margin
Dizal Jiangsu Pharmaceutical Co Ltd

96.4%
Current
35%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
96.4%
=
Gross Profit
166.4m
/
Revenue
172.6m

Gross Margin Across Competitors

Country CN
Market Cap 19.1B CNY
Gross Margin
96%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 352.5B USD
Gross Margin
67%
Country US
Market Cap 174.8B USD
Gross Margin
60%
Country US
Market Cap 133.2B USD
Gross Margin
86%
Country US
Market Cap 120.3B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.9B AUD
Gross Margin
52%
Country US
Market Cap 91.2B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 33.2B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Dizal Jiangsu Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
96.4%
=
Gross Profit
166.4m
/
Revenue
172.6m
What is the Gross Margin of Dizal Jiangsu Pharmaceutical Co Ltd?

Based on Dizal Jiangsu Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 96.4%.